Latest period
$437.27M
YoY change
+16.8%
5Y CAGR
+37.2%
Peak year (2025)
$158.70M
Latest annual
$158.70M
Total Debt history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: $158.70M
Total Debt growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: +16.8%
Total Debt history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | $158.70M | +16.8% | +$22.86M | ||
| 2024 | $135.84M | +54.5% | +$47.90M | ||
| 2023 | $87.94M | +37.0% | +$23.74M | ||
| 2022 | $64.20M | -3.6% | −$2.43M | ||
| 2021 | $66.63M | +104.0% | +$33.97M | ||
| 2020 | $32.66M | — | +$32.66M | ||
| 2019 | $0.00 | -100.0% | −$147.00K | ||
| 2018 | $147.00K | — | +$147.00K | ||
| 2017 | $0.00 | — | — |
- 2025$158.70M+16.8%
- 2024$135.84M+54.5%
- 2023$87.94M+37.0%
- 2022$64.20M-3.6%
- 2021$66.63M+104.0%
- 2020$32.66M—
- 2019$0.00-100.0%
- 2018$147.00K—
- 2017$0.00—
Total Debt values are taken from Revolution Medicines's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's latest reported total debt is $437.27M. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Revolution Medicines (RVMD) total debt totalled $158.70M – grew 16.8% year-over-year.
Across 2020–2025 (5 years), Revolution Medicines total debt produced a CAGR of +37.2% – with mixed annual results across the window.
The record annual total debt stands at $158.70M, reached in 2025; the historical low of $0.00 was recorded in 2017.
Revolution Medicines Total Debt by Year
Revolution Medicines Total Debt 2025: $158.70M
2025's total debt for Revolution Medicines came in at $158.70M, grew 16.8% from 2024. This figure represents the highest annual value in the available history.
Revolution Medicines Total Debt 2024: $135.84M
Revolution Medicines posted total debt of $135.84M in 2024, surged 54.5% from 2023.
Revolution Medicines Total Debt 2023: $87.94M
In 2023, Revolution Medicines reported total debt of $87.94M, surged 37.0% from 2022.
Revolution Medicines Total Debt 2022: $64.20M
Revolution Medicines total debt in 2022 was $64.20M, edged down 3.6% below 2021.
Revolution Medicines Total Debt 2021: $66.63M
Revolution Medicines total debt in 2021 was $66.63M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Total Debt
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation